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ABSTRACT 
Background/Objective: Patients frequently fail to adhere to their medication regimens, 
resulting in substantial public health consequences. In pediatrics, non-adherence to prescribed 
medication regimens ranges from 11% to 93%; averaging 50% non-adherence. Consequences of 
non-adherence include: inadequate or unsuccessful treatment, prolonged disease, change in 
prescription, prevention of accurate care assessment, and increased costs to the health care 
system as well as the patient. However, there is still uncertainty about the best methods to 
consistently enhance pill medication adherence in children enrolled in clinical trials. Therefore, a 
literature review was developed to include the available literature corresponding to interventions 
used to enhance patient adherence to pill medication in pediatric randomized controlled trials.  
Methods: Appropriate keywords and medical subject headings were used to search Pubmed 
(Medline), EMBASE, CINAHL, and PsychInfo for the period from January 1966 to July 2014. 
Inclusion was limited to studies of randomized controlled trials, in which participants were 18 
years and younger, and medication adherence was an outcome measure. Limits to the search 
included human subjects and English language.  
Results: The search was developed in Pubmed and translated to the other databases to provide 
1,487 total articles (935 in Pubmed, 139 in EMBASE, 258 in CINAHL, and 155 in PsychINFO). 
Joel Weissfeld, MD 
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After the deletion of duplicates, 1,204 articles remained. Article titles and abstracts were 
reviewed to omit obvious exclusions, leaving 68 articles. A full-text review was conducted to 
strictly choose articles adherent to the inclusion criteria. Five articles were chosen for the 
literature review.  
Conclusion: The interventions most effective at enhancing pill medication adherence were those 
that targeted the patient as well as their family or parent/guardian. These were especially 
effective when written or verbal commitments were made by the parent and/or patient to address 
medication adherence. Individually tailored interventions that focused on addressing behaviors 
associated with non-adherence were also effective. The interventions developed among the 
studies were mostly rated with high acceptability, feasibility, and fidelity (how well the study 
was executed). However the efficacy of the interventions assessed in this literature review needs 
to be confirmed by studies with larger sample sizes before recommended for implementation. 
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PREFACE 
This work began as a research paper intended to contribute to the vitamin D trials of Dr. 
Kumaravel Rajakumar. Dr. Rajakumar was working on a pediatric clinical trial to test his 
hypothesis that vitamin D replenishment in vitamin D-deficient obese and overweight children 
can improve their cardiometabolic health and reduce their risk of CVD later in life. My research 
served to summarize the effect of interventions on medication adherence via systematic review 
to provide Dr. Rajakumar with effective interventions to implement in his clinical trial. However, 
due to time constraints, the project was limited to a literature review. The findings can aid 
clinical researchers to enhance medication adherence in clinical trials- a critical step in 
determining the effectiveness of the study intervention.   
I would like to thank Drs. Kumaravel Rajakumar and Susan Sereika for their guidance 
through this entire project. Systematic reviews were new to me and I owe much of my learning 
experience to the both of them.  They continually met with me to discuss the project progress and 
helped me plan through the entire study. I would also like to thank Dr. Joel Weissfeld who 
served as my academic advisor through the development of this research paper. He guided me 
through the beginning stages of proposing a research paper and provided me with valuable 
feedback. I am incredibly grateful for all of the help I have received throughout the entire 
process of writing this research paper.  
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1.0  INTRODUCTION 
Medication adherence, also called medication compliance, is the extent a patient follows the 
physician-prescribed dose and duration of a medication regimen. Failure to adhere to pediatric 
(ages 0 to 18 years) regimens is a growing public health concern, estimated to occur at an 
average rate of 50% and ranging from 11-93%.1 The most obvious consequence of non-
adherence is that the patient does not receive the full benefit of treatment.  When adherence is 
limited, expected health outcomes of pediatric treatments are lessened by an average of 33%.2 
Non-adherence can also pose a problem on the interpretation of results in pediatric clinical trials. 
When the average adherence in a trial is 50%, instead of 100%, the required sample size would 
need to be increased fivefold to maintain the initial power of the study.3 Additionally, the overall 
burden of non-adherence (including adults) has been estimated to cost $100 billion in the United 
States each year and contributes to 10% of all hospital admissions.4 Overall, consequences of 
non-adherence include: inadequate or unsuccessful treatment, prolonged disease, change in 
prescription, prevention of accurate care assessment, and increased costs to the health care 
system as well as the patient.5 Taking these factors into account, interventions effective at 
enhancing adherence are needed to lessen the burden of non-adherence. 
There has been a considerable amount of research aimed at improving adherence rates in 
adults; however, the research targeting pediatric adherence is scarce. More specifically, research 
of interventions to enhance pill medication adherence in pediatrics is even more limited. Pill 
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medications are those taken in pill or tablet form, as opposed to liquid, inhalant, topical, or 
intravenous medications. Both topics of pediatrics and pill medication are unique issues that 
require interventions tailored to their specific needs.  
1.1 MEDICATION ADHERENCE IN PEDIATRICS 
Adherence in pediatric regimens relies heavily on the involvement of the parents. Non-adherence 
can be introduced when parents lack understanding of the diagnosis or have concerns about the 
medication regimen effectiveness. In a survey conducted in 2005, it was discovered that when 
parents were concerned about the dangerous effects of their child’s medications, the adherence 
rate of their child significantly dropped.6 Parents have also been found to forget half of the 
information given in a 15 minute meeting with the physician. Most of the information retained 
by the parent was related to the diagnosis in the first third of the conversation.7 Therefore, the 
families of the patient need to fully understand the importance of the regimen and be encouraged 
to ask questions, clarify understanding, and provide feedback on their experience with the 
regimen.8 Additionally, the daily hassles of life, stresses, and typical family conflicts may 
interfere with the adherence rates in pediatric medication regimes.7  
On the other hand, age differences in the pediatric population can greatly influence the 
approach needed to enhance medication adherence.7 Adolescents (ages 13 to 18 years) typically 
begin to demand independence from their parents and take control of their own bodies resulting 
in lower rates of adherence when compared to younger children.9 Therefore, older children are 
typically more involved in self medication and setting goals - making it critical to empower older 
children to take their medications and control of their own health. Altogether, many factors are 
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present within the topic of medication adherence in pediatrics and all need to be considered when 
developing an effective intervention to enhance adherence.  
1.2 PILL MEDICATION ADHERENCE 
Adherence to pill medication in pediatric regimens can be greatly influenced by the number of 
doses per day, the length of treatment, the taste of the medication, the side effects associated with 
the medicine, and the effectiveness of the medicine. The complexity of the regimen prescribed 
has been shown to be associated with a decrease in medication adherence. For example, a 
simplified regime of one pill with multiple actions has higher adherence rates than a regimen of 
multiple pills with single actions. Furthermore, among all ages of diagnosis, once or twice a day 
dose regimens have been found to be associated with higher adherence rates than three or four 
doses a day.4 In children, once or twice daily dosing is more comfortable because parents can 
remind and observe medication administering without relying on the child to take their 
medications while at school.7 Also, in a study conducted among hypertensive patients, those who 
were required to take three doses of medication each day were found to have 59% adherence 
compared to 84% adherence among the patients who were required one dose per day.4 
Additionally, adherence to medication regimens is known to decrease over time. Therefore long-
term regimens require adherence monitoring and patient follow-up to ensure medication 
adherence.10  
Among children, refusal to take medications was found to be most problematic when 
treatment was unpalatable, caused side effects, or did not offer immediate relief.11 In a trial of 
paired antibiotic arrangements, the children were found to prefer certain tastes over others. 
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Retrospective studies have also found medications with a displeasing taste to be negatively 
associated with adherence while medications with a pleasing taste were positively associated 
with adherence.10 Patients have also been found to attribute 22.5% of medication non-adherence 
to fear of side effects.4 Especially if the medication being taken was administered to treat future 
outcomes, a decrease in adherence was observed.13 A study reported a failure to pick up 
prescriptions in 20% of patients who had asymptomatic symptoms or did not feel the medication 
was needed.4  Different forms of medications have also been found to influence the adherence 
rates of regimens. From a parental perspective in earlier studies, liquid oral medications are 
preferred over solid pill medications. However, a recent randomized study of infant and toddlers 
with malaria medicine reported greater adherence to crushed pills than syrup medication. Mixed 
results have been reported when comparing inhalant medications to pills but more recent 
research has favored pills. Therefore, although there may be similarities in the difficulties 
associated with maintaining high adherence rates, pills are unique from other forms of 
medications and must be approached differently to find the best adherence enhancing techniques. 
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2.0  PUBLIC HEALTH SIGNIFICANCE 
Medication non-adherence in children is a growing public health concern due to its effect on 
treatment effectiveness, patient safety, and health care costs. In pediatrics, non-adherence to 
prescribed medication averages 50%, resulting in the reduction of expected health outcomes of 
the treatment by an average of 33%.1,2 Additional consequences of medication non-adherence to 
the safety of the patient include inadequate or unsuccessful treatment, prolonged disease, change 
in prescription, and prevention of accurate care assessment.5 Medication non-adherence also 
contributes to 10% of all hospital admissions and costs the United States health care system $100 
billion each year.4 Therefore, research to improve medication adherence in pediatrics is crucial 
for improving patient health while reducing the burden on the patient and the health care system. 
2.1 OBJECTIVE 
There is still uncertainty about the best methods to consistently enhance pill medication 
adherence in children enrolled in clinical trials. The paper reviews the literature corresponding to 
interventions to enhance pill medication adherence in randomized controlled trials in children. 
This review will assess and compare effectiveness of differing adherence interventions across 
multiple independent studies. 
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3.0  METHODS 
3.1 LITERATURE SEARCH 
The following databases were searched for the period before July 2014: Pubmed (MEDLINE), 
EMBASE, CINAHL, and PsychINFO. Appropriate keywords and medical subject headings 
(MeSH terms) were used to limit the search to the following inclusion criteria: randomized 
controlled trials, participants of 18 years and younger, medication adherence as main outcome 
measure; and the search was limited to humans and English.  
3.2 LITERATURE REVIEW 
Titles and abstracts were reviewed to exclude articles that violated one or more of the inclusion 
criteria listed above. A second full-text review was done to carefully examine which articles 
should be included based on a pre-designed inclusion criteria form. The form was more precise 
to make sure studies included exactly what the inclusion criteria entailed (Appendix).  
The articles chosen for the literature review were evaluated using the Institute of 
Medicine’s report “Finding What Works in Health Care: Standards for Systematic Reviews”.13  
For each article, the review contained an overview of the hypothesis and results, and evaluations 
for bias, relevance, and fidelity (how well the study was executed).  
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4.0  RESULTS 
The search was developed in Pubmed and translated to the other databases to identify 1,487 total 
articles (935 in Pubmed, 139 in EMBASE when limited to articles without Pubmed identification 
numbers, 258 in CINAHL, and 155 in PsychINFO). After the deletion of duplicates, 1,204 
articles remained. Inspection of titles and abstracts selected 68 articles for full text review, which 
identified five eligible articles.  
4.1 EVALUATION OF A GROUP-BASED BEHAVIORAL INTERVENTION TO 
PROMOTE ADHERENCE IN ADOLESCENTS WITH INFLAMMATORY BOWEL 
DISEASE14 
This study included participants between the ages of 11-17 years who were diagnosed with 
Crohn’s disease, ulcerative colitis, or indeterminant colitis, and were taking a current 
prescription of 6-MP/azathioprine and/or mesalamine. It was hypothesized that the participants 
randomized to a family-based group behavioral treatment, compared to usual care, would show a 
significant increase in medication adherence from baseline to post-treatment. This randomized 
controlled trial was conducted for 7 weeks by the outpatient gastroenterology clinic at a pediatric 
hospital. The intervention was a group-based treatment focused on problem solving, 
communication, cognitive restructuring, and functional-structural family therapy to improve 
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social support and adherence. Adherence was measured by pill counts, MEMS caps, parent-
reported adherence, and patient-reported adherence.  
 There were 40 total participants in the study including 30 patients with Crohn’s disease, 7 
with ulcerative colitis, and 3 with indeterminant colitis. Among the patients with Crohn’s 
disease, 28% had inactive disease, 55% had mild disease, and 17% had mild to severe disease. 
Among those with ulcerative colitis and indeterminant colitis, 40% had inactive disease, 40% 
had mild disease, and 20% had mild to severe disease. There were 24 patients prescribed 6-
MP/azathioprine, 21 patients prescribed mesalamine, and 6 patients prescribed both medicines. 
An independent sample t-test revealed no significant difference between conditions at baseline of 
demographics, disease, or adherence. Repeated measures of analysis of variance found non-
significant differences between treatment and usual care groups from baseline to post-treatment 
assessment across pill counts (p=0.95 for 6-MP/azathioprine, p=0.40 for mesalamine), MEMS 
caps (p=0.73), and parent-reported adherence assessment (p=0.33 for 6-MP/azathioprine, p=0.50 
for mesalamine). Children in the intervention group self-reported better adherence to mesalamine 
(p<0.01), but not 6-MP/azathioprine (p=0.76).  
 When assessing this study, a few possible biases were found. The sample size is small 
and may produce bias by limiting the power present to detect differences between the treatment 
group and usual care. Reporting bias is also possible due to the patients in the treatment group 
feeling influenced to report higher adherence than is true. Although the study used many 
different methods to measure adherence, the self-report adherence measures from the parent and 
the patient are subject to biases due to failure to remember accurately and pressure to report 
acceptable adherence rates.  
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 The study population was clinically diverse, a situation favoring external validity. On the 
other hand, clinical diversity limited opportunity for analyses limited to specific disease 
subgroups. The authors also mentioned poor representation of socioeconomic and ethnic 
minority groups. The intervention shows good relevance because the study did not change the 
usual care of medication and used empirically supported theory-driven components. It should 
also be an achievable intervention for the general community of patients based on the low 
frequency of visits, hours, and short intervention period. However, this intervention would 
require the assistance of a psychologist, a resource that might not be present in usual hospital 
settings. The comparator of the study is relevant because usual care is used. The outcome is 
relevant to short-term adherence but since the intervention is very short, it would not be relevant 
to long-term measures of adherence. Also, the only significant result may not be relevant because 
it came from the bias-prone measure of patient-report. Not only is this measure self-report, but a 
child also reported it. The setting is relevant to similar populations who frequent the hospital for 
their inflammatory bowel disease.  
 The fidelity of the study was not affected by the lack of a data and safety monitoring 
board because the participant’s physician prescribed the treatments. Additionally, the 
intervention posed no threats to the participant’s health. The fidelity exhibited by the training of 
the investigator is unknown because it was not reported. However, the intervention applied 
techniques generally known to psychologists. The protocol was not too complex for patients to 
follow because the investigator guided them but the behavioral modifications needed to improve 
adherence may have been complex. The feasibility of the study was demonstrated by the high 
(99%) treatment session adherence. The intervention was also perceived as highly acceptable by 
both patients and caregivers on the feasibility and acceptance questionnaire given post-treatment. 
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The fidelity of the adherence measures may have been compromised in a few different ways. The 
treatment regimen adherence questionnaire (patient- and parent-report) measure of adherence 
was developed for this study with no previous data to back up its efficacy. The authors also noted 
that 56% of the participants reported using pillboxes to organize their medications. They 
attempted to open the MEMS cap to report their adherence each time they took a pill from their 
pillbox but the efficacy of the MEMS data could have been compromised. No protocol violations 
were reported.  
 In conclusion, evidence that a family-based group behavior treatment improved 
adherence was limited to one biased patient-reported measure. The trial was perceived as highly 
feasible by the 99% treatment session attendance. The patients and caregivers also reported 70-
100% acceptability regarding the appeal and helpfulness of the intervention. Therefore, although 
the intervention did not produce significant results regarding adherence enhancement, it was 
highly valued by those who participated. Follow-up studies are needed to further address the 
significance of this intervention. A longer intervention period is recommended to give the 
intervention more time to make a lasting behavioral change to increase adherence. A more 
diverse sample in terms of SES, ethnicity, and disease severity should be included. Lastly, the 
adherence measures should be limited to fewer but more objective measures, perhaps a pill count 
or electronic pillbox.  
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4.2 MULTI-SYSTEMIC THERAPY FOR POORLY ADHERENT YOUTH WITH 
HIV: RESULTS FROM A PILOT RANDOMIZED CONTROLLED TRIAL15 
This study included children between the ages of 9 and 17 years who were receiving HIV 
management, residing in a stable placement (family), reporting less than 80% adherence in the 
last 3 months, and live within a 2-hour drive from one of the 2 clinics. The investigators 
hypothesized that multi-systemic therapy employed by home- and community-based treatment, 
compared to usual care bolstered with a single session of motivational training, would result in a 
significantly greater improvement in medication adherence. The randomized controlled trial was 
conducted for 9 months from 2 pediatric HIV/AIDS clinics. The multi-systemic therapy 
consisted of a list of evidence-based intervention techniques including: cognitive behavioral 
therapy, parent training, and behavioral family systems therapy and communication skills 
training. Families were seen an average of 2.2 visits per week for 6 months and the interventions 
were performed in homes, schools, and medical clinics. The usual care group had quarterly clinic 
visits to address medications and other health issues. They also received a single session of 
motivational intervention to increase motivation and self-efficacy of medication adherence. Self-
report was used to measure the main outcome of medication adherence during each quarterly 
research assessment (baseline, month 3, month 6, month 9). 
 Of the 34 participants and family member(s) recruited, all but 1 of them completed the 
intervention. Most of the participants were girls (65%) and African American (91%). Medication 
adherence was modeled as a dichotomous outcome of less than 90% adherence or more and the 
analysis was performed using a mixed effects regression model. The multi-systemic therapy and 
motivational intervention did not differ significantly by level of medication adherence at baseline 
(p=0.877). The medication adherence of the multi-systemic therapy group increased significantly 
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following the start of the intervention (p=0.311). However, medication adherence rates of change 
did not differ significantly between multi-systemic therapy and motivational intervention 
(p=0.693). 
 There are a few biases to discuss concerning this study. The sample size is small, and 
thus power of the study is low and and may inhibit the ability to detect differences between the 
treatment groups. Performance bias may also be present due to the individualization of the 
treatment. There is a possibility that each participant received a different intervention that could 
alter the effects of their adherence compared to others within the same group and the opposite 
group. Lastly, the self-report adherence outcome is subject to recall bias and may also be 
influenced by participants of the treatment group feeling greater pressure to report higher 
adherence levels than are true. 
 The relevance of the study population may be compromised in comparison to the rest of 
the general population. This is because the study population has a proportion of girls (65%) and 
African Americans (91%) that does not reflect the actual population of HIV patients. Also, 33 
out of the 34 of the study participants were perinatally infected with HIV, which is also non-
reflective of the general HIV population. The medication and doses used in the intervention were 
relevant because they were the same as are used in usual care. On the other hand, the 
intervention was less relevant to the general HIV population because patients do not usually get 
2.2 visits per week and are not usually influenced by medication monitoring. Additionally, this 
study used monetary incentives that influenced the continual participation but which are not 
typical in usual care. However, if incentives prove to be effective they could be easily adopted 
into usual care. The relevance of the comparator group is reduced due to the addition of the 
motivational intervention to the usual care. The motivational intervention also affects the 
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relevance of the outcome because it makes the study less comparable to current practice. The 
trial is also a short-term trial, making the outcome irrelevant to the long-term nature of the HIV 
disease. Lastly, the use of 2 different clinics makes the results more relevant to the general 
population but may still differ from the usual setting of community HIV patients.  
 The fidelity assessment found no mention of data safety monitoring, a possibly optional 
element because the intervention was deemed safe. The study implementation had high fidelity 
due to the intense investigator training and assessment. Two master-level therapists completed a 
weeklong multi-systemic therapy training course and a 1.5-day training specific to HIV care 
before delivering interventions. The therapist fidelity was assessed by monthly caregiver-
reported therapist adherence measures. The therapists received the scores of 0.76 and 0.81, 
which is well above the minimal adherence treatment value of 0.61. The motivational 
intervention fidelity was also evaluated to produce a strong fidelity score of 96. The protocol was 
complex but the frequent visits with the patient and family made it easy to follow for the 
participants. Fidelity was lowest in the self-reported measure of adherence because it is a 
subjective measurement that is vulnerable to bias. No protocol violations were reported.  
 In conclusion, this study demonstrated the feasibility of a multi-systemic therapy to 
enhance medication adherence in HIV youth. The recruitment and retention in the study was 
impressively high, as was the fidelity associated with investigator training and implementation. 
The multi-systemic therapy also appeared to increase adherence significantly in the beginning of 
the study among those who were non-adherent at baseline. However, the long-term effects of the 
intervention did not appear to be significantly better than the usual care and motivational 
intervention. Future studies are needed to implement this intervention with a larger sample size 
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and compare it to usual care instead of the additional motivational intervention. It is also 
suggested to measure adherence more objectively, perhaps by the use of MEMS caps.  
4.3 PRELIMINARY FEASIBILITY, ACCEPTABILITY, AND EFFICACY OF AN 
INNOVATIVE ADHERENCE INTERVENTION FOR CHILDREN WITH NEWLY 
DIAGNOSED EPILEPSY16 
This study included participants of 2-12 years of age who were diagnosed with epilepsy within 7 
months prior to the study and demonstrated non-adherence (<90%) at baseline. Baseline data was 
determined after a 30-day screening period to identify patient adherence levels. It was 
hypothesized that a family-tailored education and problem-solving adherence intervention, when 
compared to usual care, would enhance medication from baseline to post-intervention. This 
randomized controlled trial was a 4-month long trial conducted by a new-onset seizure clinic at a 
pediatric children’s hospital in the Midwest. After 30 days of adherence screening, the 
participants identified as “poor adherers” (<90% adherence) were randomized to the treatment or 
usual care group. Families in the intervention group received 4 intervention sessions over a 2-
month period. The intervention sessions focused on epilepsy treatment education, adherence to 
antiepileptic drugs (AEDs), and providing information on family specific epilepsy treatment 
regimen. The intervention was also used to teach ways to overcome patient-identified barriers to 
adherence. The investigators created a written action plan of agreed upon solutions to overcome 
adherence barriers and all the participants signed the plan. The family was contacted between the 
second and third session by phone or email to provide continued guidance and support on the 
action plan. MEMS caps were used as the adherence outcome measure.  
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 There were 4 families enrolled in the treatment group, 4 families in the usual care group, 
19 families exhibited good adherence (≥90% adherence at baseline), and 3 families withdrew 
prior to randomization. Due to the small sample sizes, only individual adherence changes over 
time were examined. In the intervention group, 2 of 4 families showed large improvements in 
adherence but had low baseline rates. One family had 83% baseline adherence and demonstrated 
small improvements during the treatment period. The remaining family had a baseline of 89% 
adherence and exhibited variable adherence rates throughout the treatment period. Among the 
families in the treatment group, the mean percent change in adherence from baseline to post-
intervention was a 31.5% increase. The usual care families had baseline rates of 68, 80, and 83 
(the last family was dropped due to post-treatment data being missing). Two families showed a 
small improvement in adherence (2-7%) and the other family showed a 19% increase in 
adherence.  
 There are a few biases to consider when assessing this study. The extremely small sample 
size can limit the effect of the randomization and bring forth allocation/selection bias. For 
example, it seems that the treatment group had families with lower baseline adherence than the 
usual care group. This could have influenced the greater adherence improvement in the treatment 
group. Additionally, the one dropout could bias comparisons between groups. Perhaps being in 
the treatment group makes the family more likely to report their adherence correctly compared to 
the usual care group.  
 The study population was relevant to newly diagnosed children with epilepsy who are 
similar in disease duration. However, statistical comparisons on demographics, medical 
background, and baseline adherence were not conducted because of the small sample size. The 
run-in phase also excluded participants with high adherence (≥90%) but a one-month screening 
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period may have been too short to make a judgment on medication adherence behavior. The 
sample population therefore could have excluded participants who were in need of a medication 
adherence intervention. The intervention was relevant due to the use of medications prescribed in 
usual care. However, the intervention conducted in the treatment group could have offered 
additional guidance on how to properly use the MEMS caps, thus influencing proper use of the 
MEMS caps more in the treatment group than the usual care group. This effect may explain the 
missing post-treatment data in the usual care group. The comparator was relevant to the general 
population because usual care was implemented. The outcome lacks relevance to long-term 
adherence rates because the intervention only lasted for 4 months. Lastly, the setting and 
recruitment took place at a single site, which lessens the relevance to differing sites and 
decreases external validity.  
 The absence of a data and safety monitoring board did not affect the fidelity of the study 
because the intervention was harmless. The training developed by the two pediatric 
psychologists specializing in epilepsy showed high fidelity. Masters level students in clinical 
counseling psychology programs were trained as interventionists. They shadowed the 
psychologists in the medical clinic, attended comprehensive lectures that reviewed intervention 
materials, performed role-playing exercises to mimic intervention sessions, and received live 
feedback to optimize delivery. The psychologists, to ensure treatment fidelity, also supervised 
the interventionists weekly. The protocol was not too complex for the participants to follow due 
to the written document given to the families to establish intervention methods and the follow-up 
phone calls to answer questions. The intervention was made easy for the families by allowing 
them to meet on preferred date, time, and location- resulting in 100% retention (among those 
assigned to the intervention group). The adherence was high in fidelity due to the use of MEMS 
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caps to objectively monitor medication adherence. There were no protocol violations reported. In 
fact, the intervention families reported high ratings in the feasibility and acceptability 
questionnaires.  
 In conclusion, this study demonstrated that the use of a family-tailored education and 
problem-solving adherence intervention is acceptable and feasible to families. Promising 
improvements in adherence for children with newly diagnosed epilepsy were also recorded. 
However, future studies are needed to confirm the results of this study due to the very small 
sample size. Follow-up studies should include multiple sites, increase the sample size, and 
conduct the study for a longer period of time. The run-in period to identify good adherence from 
bad adherence should also be lengthened to eliminate any bias of high adherence associated with 
new treatment.  
4.4 PREVENTION OF NON-ADHERENCE TO NONSTEROIDAL ANTI-
INFLAMMATORY MEDICATIONS FOR NEWLY DIAGNOSED PATIENTS WITH 
JUVENILE RHEUMATOID ARTHRITIS17 
This randomized trial included children and adolescents of 2-16 years old who were newly 
diagnosed with juvenile rheumatoid arthritis (JRA) within the year prior to study inclusion. It 
was hypothesized that the patients randomized to an educational and behavioral intervention, 
compared to education received in usual care, would have better adherence to their JRA 
medication regime of nonsteroidal anti-inflammatory drugs (NSAIDs) by the end of the year of 
treatment. The intervention consisted of a nurse-administered 30-minute clinic visit followed by 
phone calls to the participants and their parents every 2 weeks for 2 months, then monthly for the 
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remaining 10 months. The participants viewed a 10-minute video during the clinic visit and 
received a booklet describing adherence-enhancing strategies. Throughout the clinic visit and 
phone calls, the investigator used the applied behavior analytic theory with the participant and 
parents to identify and develop cueing, monitoring, positive reinforcement, and discipline needed 
to enhance adherence to medication. In the control group the participants and parents viewed a 
13-minute program that reviewed types of JRA, signs, symptoms, and medication treatment. 
They were also given pamphlets made by the Arthritis Foundation concerning the medication 
purpose, benefit, potential side effects, and how to minimize the side effects. The education 
component was the same throughout the treatment group and the usual care group. Medication 
Event Monitoring System (MEMS) caps measured the main outcome, medication adherence to 
NSAIDs. This electronic medication bottle cap records the date and time of each bottle opening.  
The complete adherence results were available for 34 people (19 in the experimental 
group and 15 in the control), accounting for 65% of the participants (7 were taken off 
medications, 7 had incomplete data, and 6 withdrew). Due to some groups missing daily 
adherence data, each participant’s available daily data was averaged over a 7-day period to get 
56 averages (4 during baseline and 52 during follow-up). A one-tailed, alpha=0.05, Mann-
Whitney test was used to test predicted group differences in post-intervention adherence. After 
the 52-week follow-up significantly better adherence rates were found in the experimental group 
(77.7% adherence) compared to the control group (56.9% adherence) (p=0.02). Group 
differences were tested by a Mann-Whitney test. The treatment and control groups were not 
different on baseline adherence, gender, ethnicity, JRA subtype, or socioeconomic status (SES). 
There are several biases that need to be considered within this study. Due to low initial 
participation (60%) and high subsequent attrition (37%), the sample size was low and may have 
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produced an insufficient power to detect important group differences. Although the use of newly 
diagnosed patients was good for controlling the duration of disease, newly diagnosed patients are 
also more likely to go into remission and get taken off of medication. Also, the dropouts were 
found to have significantly milder disease at baseline, perhaps contributing to lesser need of 
medication and therefore lower adherence rate.  
The population used for the study was relevant to the population of newly diagnosed 
children and adolescents with JRA but may not reflect the population with children with long-
term JRA. The intervention intensity and delivery is relevant because it could be adopted by 
other clinics quite easily and can be implemented by a nurse. The comparator was relevant to the 
general population of JRA patients because it was usual care and is similarly administered 
among other clinics. However, the setting of this particular clinic may be different than other 
clinics in the USA. The setting would be more relevant to the rest of the country if the 
intervention were extended to multiple sites. The outcome is relevant because it is measured with 
MEMS caps to produce an objective continuous measure that is reflective of the general 
population. However, the outcome is defined as adherence throughout the period of a year and is 
therefore difficult to determine the long-term effect on adherence. One year may seem like a 
sufficient length of time but when relating the results to a chronic illness that can last a lifetime, 
longer studies will be needed.  
When assessing the fidelity of the study, it was found that there was no mention of an 
adverse event monitoring board. However, the study did not tamper with physician-recommend 
JRA treatments. To increase the fidelity of the administering of the intervention, the nurse 
investigator followed a group-specific protocol checklist for the clinic visit and phone calls. 
There was also a research assistant who monitored the clinic intervention to ensure the correct 
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implementation of the protocol. The protocol does not seem too complex for the participants and 
parents to follow because the nurse reviewed and rehearsed strategies with them. The nurse also 
followed up with phone calls to answer questions and continually reinforce the protocol. The 
adherence measure performed by MEMS caps also improved fidelity by using an objective and 
continuous measure of adherence to standardize the results and eliminate recall bias. Finally, 
there did not appear to be any problems with the nurse adhering to the protocol throughout the 
intervention.  
In conclusion, the study identified strong support for an intervention composed of the 
combination of education and behavior to enhance adherence in JRA. The combination of the 
two adherence strategies is significantly better than education alone on the adherence outcome. 
Additionally, the intervention would be a relatively easy intervention to implement in other 
clinics. However, a future study with a larger sample size is needed to confirm the results found 
with greater power. 
4.5 THE EFFECT OF VERBAL COMMITMENT AND TREATMENT CHOICE ON 
MEDICATION COMPLIANCE IN A PEDIATRIC SETTING18 
This study included participants between the ages of 1-14 years of age who were diagnosed with 
acute otitis media and starting a 10-day treatment of amoxicillin or pediazole. The investigators 
hypothesized that verbal commitment to medication regime and/or parent choice between 2 
essentially equivalent antibiotic regimens, when compared to neither intervention, would 
increase the medication adherence throughout the 10-day antibiotic treatment. This physician-
blinded, randomized trial targeted the parents of the patient of a private practice pediatrician. For 
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the verbal commitment intervention the physician asked the parent of the diagnosed patient if 
they promised to give the child all the recommended doses. The choice manipulation 
intervention consisted of the physician asking the parent to choose either amoxicillin or 
pediazole for the child’s treatment. The main outcome of medication adherence was measured by 
self-report.  
 The study included 89 total participants and 82 completed the study. Overall, 51% of the 
prescriptions were for pediazole and 49% for amoxicillin. The antibiotic regimen type did not 
differ in proportions between experimental conditions. Patients given amoxicillin and pediazole 
had similar compliance. A 2x2 between-subjects (commitment: yes/no x choice: yes/no) analysis 
of variance indicated that subjects with commitment took significantly more of their medication 
than the non-commitment group. No other effect of this analysis was significant.  
 The study may be subject to bias in a few different ways. The self-reported medication 
adherence measure can present recall bias due to the forgetfulness of the parent or pressure to 
report favorable results. Especially within the commitment group, the parents may feel more 
pressure to report high adherence to the physician. The self-reported adherence measure was also 
collected via follow-up interview with the physician. Therefore, the way the physician 
approached the questions could have lead to response bias. Additionally, the study did not 
investigate the reasons leading to the failure of 7 participants to return for the follow-up.  
The population of the study is limited in its relevance to the general population because 
the study was conducted in a single private practice consisting primarily of patients with private 
insurance. Furthermore, the authors did not compare the demographic characteristics of the 
participants to the general otitis media population to assess the relevance. However, the 
population was relevant because the study did not impose strict exclusion criteria to limit the 
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study population to a small subset of children diagnosed with acute otitis media. The intervention 
provided relevance through the consistency of the medication regimen with standard practice. 
The intervention was also relevant because the parents were unaware that medication reporting 
would take place until the follow-up interview, which prevented any change in medication 
behavior due to the anticipation of being assessed on adherence. The comparator was relevant 
because usual care was used. The outcomes were measured by self-report, which may not 
accurately reflect the true rates of adherence that would result from the interventions. 
 There was no drop in fidelity due to the lack of a data safety monitoring board. A 
monitoring board was not required in this trial because the patient’s pediatrician prescribed the 
usual treatment for acute otitis media. There was also no specific training needed for the 
physician other than the best way to solicit drug preferences. The physician followed a protocol 
of specific questions to ask the patient’s parent. The protocol was very simple for the patient to 
follow and the treatment only lasted 10 days, resulting in high fidelity. The adherence measure 
may have exhibited moderate fidelity. They used a urine analysis to detect the prescribed 
antibiotic using the Bacillus subtilis method but only 10 urine samples were conducted. A point-
biserial correlation was used to investigate the degree of the relationship between the self-
reported adherence scores (on an interval scale) and the presence of the antibiotic in the urine (on 
a nominal dichotomous scale). The point-biserial relationship between self-reported adherence 
and urine results were strong (p<0.001, two tail) to support validity of the measure. However, the 
urine test only detects whether antibiotics were taken in the last 24 hours. Therefore, the results 
could be biased by the patient’s increased likelihood of taking the medication before they visit 
the physician. Protocol violations were not reported.  
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 Overall, this study demonstrated that verbal commitment from the patient’s parent, 
compared to usual care, significantly increases medication adherence in children with an acute 
otitis media infection. Giving the parent a choice of medication, however, showed no benefit to 
enhancing adherence. The intervention was very simple with a protocol that was easy to 
implement and follow. The cost of this intervention to acquire verbal commitment is also very 
low, making this a cost-efficient procedure to enhance adherence and treatment outcome. Future 
studies are needed to confirm these results in a more diverse population. The self-reported 
adherence measures should also be more standardized by having the patient fill out a 
questionnaire instead of having the physician interview the parent. It would also be beneficial to 
conduct a urine test for adherence on all the patients or implement a different type of objective 
measure, such as MEMS caps.  
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5.0  DISCUSSION 
These five studies assessed unique interventions designed to improve pill medication adherence 
in children. Interventions included: parent-focused verbal commitment, education and behavior 
intervention, family-tailored education and problem solving, multi-systemic therapy, and family-
based group behavior treatment. All of them incorporated the family or a parent/guardian in the 
intervention in some way or another. Therefore, it seems that interventions targeting families 
and/or parents of the participant are effective in achieving acceptability and feasibility of the 
intervention. In a previous study it was found that family closeness and cohesiveness of family 
interaction patterns strongly affect adherence. This may be because parents usually establish 
behavioral norms and model health behaviors and coping skills for their children.2 
Problem solving, verbal commitment, and individually tailored interventions seem to be 
the most effective at modifying behavior toward positive adherence behavior. It also seems that 
interventions targeting behavior modification and education are more effective than interventions 
targeting education alone. Behavioral and multi-component interventions have been found to 
increase medication adherence but education is not effective by itself.19, 20 Education is included 
in most cases of usual care in the studies examined, therefore low adherence rates in the usual 
care group suggests education alone is not acceptable in enhancing adherence in current practice. 
Two limitations, small sample size and short duration intervention, were common to 
studies included in this review. Small sample sizes reduce power to detect clinically important 
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effects. Additionally, in extreme situations, randomization may be ineffective. Therefore, 
although the acceptability and feasibility of most of the interventions were excellent, the studies 
need to be repeated with larger sample sizes before the results can be confirmed. It is also 
interesting that the studies implemented short trials when most of them were dealing with 
chronic issues. Patients with chronic disease need to be approached with long-term interventions 
because the need to adhere everyday, as well as the endless treatments, procedures and visits can 
be overwhelming for the patients and result in a drop in adherence rate. A reduction in 
medication adherence can result in less effective treatments and a worsening of the disease.2 
Adherence rates in chronically ill patients have been found to decrease over time, thus 
interventions seeking to improve medication adherence in chronic disease should present long-
term implementation.21 Additionally, a couple of the trials failed to implement usual care as the 
comparator group, which makes the results less relevant to the general population.  
One of the factors that played a large role in biases and uncertainty among the articles 
reviewed were the techniques used to measure the medication adherence. The measurement of 
medication adherence is not simple due to the lack of a proven gold standard.9 The 
measurements used in the studies were urine assays, self-report, MEMS caps, and pill counts. 
The use of urine assays is a direct method of measuring adherence because it provides proof that 
the patient took the medication. The other methods of measuring adherence are indirect methods 
because they do not provide proof of medication ingestion.22 The use of urine assays can provide 
a quantitative measurement of medication adherence; however, it also has shortcomings. The 
measurement can only effectively detect the drug in the urine if it was taken within 24 hours. 
Therefore, unless the urine is frequently tested, the results can be biased based on the patient’s 
increased likelihood of taking the medication before they go in for a check-up.22 The advantage 
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of self-report is that it can provide information regarding the nature of an adherence problem. It 
is also the simplest and cheapest method to address medication adherence. However, previous 
studies have discovered that patients who report poor adherence are usually correct, whereas 
patients who report good adherence are less often correct. Another factor that can affect the 
validity of the self-report method is the skill of the interviewer and/or construction of the 
adherence question(s). Overall, self-report is generally considered an unreliable method of 
accurately measuring adherence.22  
Pill counts are one of the most common measures used for medication adherence because 
of the simplicity of the measure and the low cost. However, pill counts have been found to 
overestimate medication adherence. Some patients, knowing the purpose of the pill count is to 
measure their adherence, will purposely not return the pills for counting or will dump pills out of 
the bottle to make it look like they were taking the medication. Pill counts are also insufficient 
for identifying the nature of an adherence problem, they can only provide a percentage of total 
consumption.22 Therefore, the most recent technology development of MEMS caps has been 
adopted in many research and clinical settings. MEMS caps record the date and time that the 
patient takes their medicine by detecting when the pill bottle is opened. This is useful because it 
provides continuous data and can provide information regarding the precision with which the 
patient adheres to their specific regimen. However, patients may purposely open the bottle to 
make it look like they were taking the medicine. Also, some patients prefer to use daily pillboxes 
to make their medication regimen more manageable and do not use the bottle fitted with the 
MEMS caps for medication administration.22 Altogether, MEMS caps provide the most reliable 
data on medication adherence but the type of adherence measure should be selected based on the 
goals and resources of each study. 
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5.1 CONCLUSION 
The interventions most effective at enhancing pill medication adherence were those that 
targeted the patient as well as their family or parent/guardian. These were especially effective 
when written or verbal commitments were made by the parent and/or patient to address 
medication adherence. Individually tailored interventions that focused on addressing behaviors 
associated with non-adherence were also effective. The interventions developed among the five 
studies reviewed were mostly rated with high acceptability, feasibility, and fidelity. However 
the efficacy of the interventions assessed in this literature review need to be confirmed by 
studies with larger sample sizes before recommended for implementation. 
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APPENDIX: Full-Text Review Form  
Journal	  Title:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
First	  Author:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Year:	   	  	   	  	  
Inclusion	  Criteria:	  Failure	  to	  check	  any	  of	  these	  boxes	  leads	  to	  study	  exclusion	  
	  	  
	   	   	  
	  	  
1.	  English	  Language:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
2.	  Age	  specified	  and	  within	  0-­‐18	  years	  only:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
3.	  Medication	  used	  was	  pill	  or	  tablet	  form:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
4.	  Randomized	  controlled	  trial:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
5.	  Medication	  adherence	  is	  main	  outcome:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
6.	  Intervention	  to	  enhance	  adherence:	   	  	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	  
Exclusion	  Criteria:	  Any	  of	  these	  boxes	  checked	  leads	  to	  study	  exclusion	  
	  	  
	   	   	  
	  	  
7.	  Study	  on	  psychological	  disorders:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
8.	  Contraceptive	  study:	   	  	   	  	   	  	   	  	  
	  	  
	   	   	  
	  	  
9.	  Animal	  subjects:	   	  	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	  
Conclusion:	  Include	  article	  for	  literature	  review?	  	   Yes	   No	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